Effectiveness and safety of minocycline 4% cream vs. clindamycin 1% cream in the treatment of mild to moderate acne vulgaris: A non-randomized clinical trial
Journal of Pakistan Association of Dermatologists · 30.06.2026 · 36 (2) · 202-208
DOI: 10.66344/jpad.v36i2.3324 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Pakistan Association of Dermatologists, online erschienen am 30.06.2026. Verfasst von Mahnoor Tahir und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acne vulgaris is a polyetiological disease, associated with significant physical and psychosocial morbidity. Despite the proven efficacy, long-term use of oral minocycline is limited by its potential systemic side effects. Recent developments reveal topical minocycline 4% formulations found to be effective in mild to moderate acne vulgaris with minimum side effects.
Objective
To compare the effectiveness and safety of minocycline 4% cream with clindamycin 1% cream in the treatment of mild to moderate acne vulgaris.
Methods
In this non-randomized, prospective case-control clinical trial conducted at the Dermatology OPD, Ghurki Trust Teaching Hospital, Lahore, a total of 62 patients aged 12-45 years with mild to moderate acne were enrolled and divided into two groups. Group A (n=31) was treated with clindamycin 1% cream and group B (n=31) with minocycline 4% cream for 12 weeks. The effectiveness was determined using the Global Acne Assessment Score (GAAS) and the Investigator’s Global Assessment (IGA) at baseline and week 12. Safety was determined by monitoring any local side effect. Relapses were assessed after 24 weeks.
Results
Both topical treatments were effective in terms of improvement GAAS/IGA scores (P
Zitieren
APA
Tahir, M., Salim, M. S., Hanif, S., Shaukat, R., Hamadani, A., Chattha, A. A., Kausar, I., Javaid, K., & Nabi, H. (2026). Effectiveness and safety of minocycline 4% cream vs. clindamycin 1% cream in the treatment of mild to moderate acne vulgaris: A non-randomized clinical trial. Journal of Pakistan Association of Dermatologists, 36(2), 202-208. https://doi.org/10.66344/jpad.v36i2.3324
Vancouver
Tahir M, Salim MS, Hanif S, Shaukat R, Hamadani A, Chattha AA, et al. Effectiveness and safety of minocycline 4% cream vs. clindamycin 1% cream in the treatment of mild to moderate acne vulgaris: A non-randomized clinical trial. Journal of Pakistan Association of Dermatologists. 2026;36(2):202-208. doi:10.66344/jpad.v36i2.3324
BibTeX
@article{Tahir2026,
author = {Tahir, Mahnoor and Salim, Mahnoor Shaukat and Hanif, Sumera and Shaukat, Rabia and Hamadani, Aliza and Chattha, Ayesha Arshad and Kausar, Iram and Javaid, Kiran and Nabi, Haroon},
title = {Effectiveness and safety of minocycline 4% cream vs. clindamycin 1% cream in the treatment of mild to moderate acne vulgaris: A non-randomized clinical trial},
journal = {Journal of Pakistan Association of Dermatologists},
year = {2026},
volume = {36},
number = {2},
pages = {202--208},
doi = {10.66344/jpad.v36i2.3324}
}
EUVIMED